Balance Sheet Akeso, Inc.

Equities

9926

KYG0146B1032

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. Other stock markets 01:38:03 11/07/2025 pm IST			5-day change	1st Jan Change
113.20 ^HKD	+4.52%		+6.69%	+86.49%

03/07	Summit, AstraZeneca in talks over $15 billion cancer drug licensing deal, Bloomberg News reports	RE
03/07	Akeso's First Bispecific Adc (Trop2/Nectin4 Adc) Enters Clinical Trials, Strengthening Leadership in 'Io+Adc'2.0 Strategy	CI

219efa6bbfd9efea2ae98c62.lyaHUN5lFXBVnylVQ1UejUGdevPhJFi_H5AmZ6_U6CU.p0fLI40XWzEl00ESdBFfyAnwEaOyThHwL-QWF-SjvB3uc8Voj1BMKBvbeA

Published financial data: AKESO, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	-	23Cr	84Cr	452.63Cr	212.39Cr
Total Revenues	-	23Cr	84Cr	452.63Cr	212.39Cr
Cost of Goods Sold, Total	19.03L	3.02Cr	10Cr	14Cr	30Cr
Gross Profit	-19.03L	20Cr	73Cr	438.87Cr	182.27Cr
Selling General & Admin Expenses, Total	25Cr	42Cr	75Cr	109.05Cr	120.54Cr
R&D Expenses	77Cr	112.3Cr	132.31Cr	125.4Cr	118.77Cr
Other Operating Expenses	1L	1.38Cr	20Cr	28Cr	16Cr
Other Operating Expenses, Total	102.17Cr	155.95Cr	227.21Cr	262.17Cr	255.27Cr
Operating Income	-102.36Cr	-136.4Cr	-153.76Cr	176.71Cr	-73Cr
Interest Expense, Total	-79.87L	-1.04Cr	-4.33Cr	-8.7Cr	-6.83Cr
Interest And Investment Income	4.15Cr	2.28Cr	2.75Cr	17Cr	23Cr
Net Interest Expenses	3.35Cr	1.24Cr	-1.58Cr	8.07Cr	17Cr
Income (Loss) On Equity Invest.	-	-	-	-19Cr	-6.85Cr
Currency Exchange Gains (Loss)	1.25Cr	51.62L	-	14Cr	7.73Cr
Other Non Operating Income (Expenses)	6.95Cr	8.84Cr	13Cr	15Cr	5.47Cr
EBT, Excl. Unusual Items	-91Cr	-125.81Cr	-142.22Cr	194.25Cr	-50Cr
Gain (Loss) On Sale Of Investments	-	-	-	-	-3L
Other Unusual Items	-41Cr	2T	30T	-	49T
EBT, Incl. Unusual Items	-132.06Cr	-125.81Cr	-142.22Cr	194.25Cr	-50Cr
Income Tax Expense	-	-	-	2L	-
Earnings From Continuing Operations	-132.06Cr	-125.81Cr	-142.22Cr	194.24Cr	-50Cr
Net Income to Company	-132.06Cr	-125.81Cr	-142.22Cr	194.24Cr	-50Cr
Minority Interest	14Cr	18Cr	25Cr	8.59Cr	-1.34Cr
Net Income - (IS)	-117.71Cr	-107.49Cr	-116.84Cr	202.83Cr	-51Cr
Preferred Dividend and Other Adjustments	-14Cr	-	-	-	-
Net Income to Common Incl Extra Items	-103.64Cr	-107.49Cr	-116.84Cr	202.83Cr	-51Cr
Net Income to Common Excl. Extra Items	-103.64Cr	-107.49Cr	-116.84Cr	202.83Cr	-51Cr
Per Share Items
Net EPS - Basic	-1.65	-1.32	-1.42	2.42	-0.6
Basic EPS - Continuing Operations	-1.65	-1.32	-1.42	2.42	-0.6
Basic Weighted Average Shares Outstanding	63Cr	82Cr	82Cr	84Cr	85Cr
Net EPS - Diluted	-1.65	-1.32	-1.42	2.42	-0.6
Diluted EPS - Continuing Operations	-1.65	-1.32	-1.42	2.42	-0.6
Diluted Weighted Average Shares Outstanding	63Cr	82Cr	82Cr	84Cr	85Cr
Normalized Basic EPS	-0.67	-0.74	-0.77	1.55	-0.38
Normalized Diluted EPS	-0.67	-0.74	-0.77	1.55	-0.38
Supplemental Items
EBITDA	-100.8Cr	-131.63Cr	-144.58Cr	189.24Cr	-56Cr
EBITA	-102.36Cr	-136.4Cr	-153.76Cr	176.71Cr	-73Cr
EBIT	-102.36Cr	-136.4Cr	-153.76Cr	176.71Cr	-73Cr
EBITDAR	-100.66Cr	-131.44Cr	-144.46Cr	189.49Cr	-55Cr
Total Revenues (As Reported)	-	23Cr	84Cr	452.63Cr	212.39Cr
Effective Tax Rate - (Ratio)	-	-	-	0.01	-
Total Deferred Taxes	-	-	-	2L	-
Normalized Net Income	-42Cr	-60Cr	-64Cr	130Cr	-33Cr
Interest Capitalized	92.73L	1.44Cr	2.54Cr	3.9Cr	2.97Cr
Interest on Long-Term Debt	4L	5L	5L	7L	5L
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	18Cr	55Cr	89Cr	100.18Cr
General and Administrative Expenses	25Cr	24Cr	20Cr	20Cr	20Cr
Research And Development Expense From Footnotes	77Cr	112.3Cr	132.31Cr	125.4Cr	118.77Cr
Net Rental Expense, Total	13.8L	19.39L	12.33L	25.54L	29.02L
Imputed Operating Lease Interest Expense	3L	7L	5L	10.57L	7L
Imputed Operating Lease Depreciation	11.29L	12.14L	7L	14.97L	22.47L
Stock-Based Comp., G&A Exp. (Total)	35Cr	4.31Cr	-	-	-
Stock-Based Comp., Other (Total)	-	14Cr	4.86Cr	3.43Cr	64.24L
Total Stock-Based Compensation	35Cr	18Cr	4.86Cr	3.43Cr	64.24L

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	268.45Cr	264.16Cr	209.24Cr	154.23Cr	691.81Cr
Short Term Investments	19.47L	37.91L	28.18L	28.68L	49.85L
Trading Asset Securities, Total	11Cr	-	20Cr	85Cr	43Cr
Total Cash And Short Term Investments	279.64Cr	264.54Cr	229.11Cr	239.76Cr	734.88Cr
Accounts Receivable, Total	-	10Cr	27Cr	30Cr	52Cr
Other Receivables	9.93Cr	18Cr	12Cr	6.64Cr	7.26Cr
Total Receivables	9.93Cr	28Cr	39Cr	36Cr	60Cr
Inventory	6.12Cr	20Cr	34Cr	39Cr	71Cr
Other Current Assets, Total	4.44Cr	2.9Cr	3.3Cr	252.53Cr	3.88Cr
Total Current Assets	300.13Cr	315.23Cr	305.85Cr	567.68Cr	869.16Cr
Gross Property Plant And Equipment	81Cr	159.05Cr	232.45Cr	344.79Cr	400.31Cr
Accumulated Depreciation	-4.95Cr	-8.59Cr	-16Cr	-29Cr	-45Cr
Net Property Plant And Equipment	76Cr	150.46Cr	216.27Cr	316.2Cr	355.02Cr
Long-term Investments	-	-	1Cr	31Cr	41Cr
Other Intangibles, Total	12.3L	39.8L	84.96L	64.17L	1.18Cr
Other Long-Term Assets, Total	9.44Cr	14Cr	26Cr	3.04Cr	8.66Cr
Total Assets	385.62Cr	480.58Cr	549.59Cr	918.11Cr	1.28TCr
Liabilities
Accounts Payable, Total	11Cr	21Cr	31Cr	35Cr	43Cr
Accrued Expenses, Total	3.5Cr	8.72Cr	13Cr	19Cr	35Cr
Short-term Borrowings	-	3.8Cr	22Cr	29Cr	-
Current Portion of Long-Term Debt	1.38Cr	75.77L	22Cr	10Cr	54Cr
Current Portion of Leases	28.64L	78.54L	58.98L	1.45Cr	96.65L
Current Income Taxes Payable	11.22L	10.37L	11.33L	11.52L	11.69L
Unearned Revenue Current, Total	-	-	59.59L	44.27L	3.73Cr
Other Current Liabilities	46.14L	31Cr	46Cr	25Cr	33Cr
Total Current Liabilities	17Cr	66Cr	136.11Cr	120.46Cr	168.66Cr
Long-Term Debt	18Cr	80Cr	142.13Cr	257.73Cr	340.61Cr
Long-Term Leases	37.02L	22.37L	59.54L	86.05L	7L
Unearned Revenue Non Current	5.34Cr	6.39Cr	16Cr	87Cr	91Cr
Deferred Tax Liability Non Current	-	-	-	2L	2L
Total Liabilities	41Cr	152.55Cr	294.79Cr	466.23Cr	600.15Cr
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	55T	57T	59T	59T	63T
Additional Paid In Capital	263.16Cr	400.7Cr	458.54Cr	458.54Cr	740.96Cr
Retained Earnings	-167.43Cr	-274.93Cr	-391.77Cr	-189.11Cr	-240.43Cr
Comprehensive Income and Other	222.82Cr	190.62Cr	196.79Cr	199.8Cr	180.86Cr
Total Common Equity	318.55Cr	316.41Cr	263.56Cr	469.23Cr	681.4Cr
Minority Interest	26Cr	12Cr	-8.76Cr	-17Cr	-6.05Cr
Total Equity	345.04Cr	328.03Cr	254.8Cr	451.88Cr	675.35Cr
Total Liabilities And Equity	385.62Cr	480.58Cr	549.59Cr	918.11Cr	1.28TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	79Cr	82Cr	84Cr	84Cr	90Cr
ECS Total Common Shares Outstanding	79Cr	82Cr	84Cr	84Cr	90Cr
Book Value / Share	4.05	3.87	3.13	5.58	7.59
Tangible Book Value	318.43Cr	316.01Cr	262.71Cr	468.59Cr	680.22Cr
Tangible Book Value Per Share	4.05	3.87	3.12	5.57	7.58
Total Debt	20Cr	86Cr	187.91Cr	299.09Cr	395.19Cr
Net Debt	-259.75Cr	-178.6Cr	-41Cr	59Cr	-339.69Cr
Debt Equivalent Oper. Leases	1.1Cr	1.55Cr	98.64L	2.04Cr	2.32Cr
Minority Interest, Total (Incl. Fin. Div)	26Cr	12Cr	-8.76Cr	-17Cr	-6.05Cr
Equity Method Investments, Total	-	-	-	29Cr	40Cr
Account Code - Inventory Valuation	6	5	6	6	6
Inventories - Raw Materials, Total	6.12Cr	16Cr	17Cr	21Cr	31Cr
Inventories - Work In Process, Total	-	1.69Cr	13Cr	14Cr	34Cr
Inventories - Finished Goods, Total	-	1.48Cr	4.41Cr	3.91Cr	6.29Cr
Buildings, Total	6.46Cr	39Cr	65Cr	84Cr	142.06Cr
Machinery, Total	15Cr	42Cr	71Cr	88Cr	124.68Cr
Full Time Employees	746	1.86T	2.34T	2.78T	3.04T
Accumulated Allowance for Doubtful Accounts (Supple)	-	30T	5L	13.33L	38.81L

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-117.71Cr	-107.49Cr	-116.84Cr	202.83Cr	-51Cr
Depreciation & Amortization - CF	2.17Cr	5.7Cr	10Cr	14Cr	19Cr
Depreciation & Amortization, Total	2.17Cr	5.7Cr	10Cr	14Cr	19Cr
Amortization of Deferred Charges, Total - (CF)	4L	12.35L	22.25L	22.39L	24.23L
(Gain) Loss From Sale Of Asset	-	-	-	-	26T
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	19Cr	6.85Cr
Stock-Based Compensation (CF)	35Cr	18Cr	4.86Cr	3.43Cr	64.24L
Provision and Write-off of Bad Debts	-	30T	4L	9L	25.48L
Other Operating Activities, Total	19Cr	-27Cr	-29Cr	-35Cr	-8.43Cr
Change In Accounts Receivable	-	-10Cr	-17Cr	-2.54Cr	-23Cr
Change In Inventories	-4.76Cr	-13Cr	-15Cr	-5.43Cr	-33Cr
Change In Accounts Payable	6.97Cr	9.78Cr	10Cr	4.59Cr	7.04Cr
Change in Unearned Revenues	6.08Cr	7.97Cr	9.24Cr	41Cr	2.51Cr
Change in Other Net Operating Assets	-8.43Cr	17Cr	19Cr	4.39Cr	26Cr
Cash from Operations	-62Cr	-100.12Cr	-124.04Cr	246.78Cr	-53Cr
Capital Expenditure	-44Cr	-71Cr	-78Cr	-72Cr	-59Cr
Sale of Property, Plant, and Equipment	9T	7L	6T	2T	-
Sale (Purchase) of Intangible assets	-42.08L	-39.85L	-2.69Cr	-16Cr	-79.63L
Investment in Marketable and Equity Securities, Total	-11Cr	11Cr	-21Cr	-81Cr	43Cr
Other Investing Activities, Total	76.63L	2.59Cr	12Cr	-231.09Cr	-135.87Cr
Cash from Investing	-56Cr	-58Cr	-89Cr	-399.72Cr	-152.29Cr
Long-Term Debt Issued, Total	18Cr	74Cr	105.05Cr	147.38Cr	131.87Cr
Total Debt Issued	18Cr	74Cr	105.05Cr	147.38Cr	131.87Cr
Long-Term Debt Repaid, Total	-15Cr	-9.78Cr	-5.48Cr	-39Cr	-37Cr
Total Debt Repaid	-15Cr	-9.78Cr	-5.48Cr	-39Cr	-37Cr
Issuance of Common Stock	271.45Cr	99Cr	50Cr	-	285.11Cr
Repurchase of Common Stock	-	-5.17Cr	-	-	-
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	13Cr	79.33L	-1.03Cr	-13Cr	-41Cr
Cash from Financing	287.83Cr	158.66Cr	148.58Cr	96Cr	338.93Cr
Foreign Exchange Rate Adjustments	-21Cr	-4.86Cr	9.51Cr	1.85Cr	3.46Cr
Net Change in Cash	149.85Cr	-4.29Cr	-55Cr	-55Cr	137.34Cr
Supplemental Items
Cash Interest Paid	34.29L	1.27Cr	5.53Cr	12Cr	12Cr
Cash Income Tax Paid (Refund)	-	-	-	-	-
Levered Free Cash Flow	-79Cr	-118.91Cr	-158.96Cr	-227.39Cr	-111.36Cr
Unlevered Free Cash Flow	-78Cr	-118.27Cr	-156.26Cr	-221.95Cr	-107.09Cr
Change In Net Working Capital	6.23Cr	-15Cr	-4.65Cr	262.15Cr	22Cr
Net Debt Issued / Repaid	3.35Cr	64Cr	100Cr	108.69Cr	95Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-23.14	-19.68	-18.66	15.05	-4.16
Return on Total Capital	-24.69	-21.89	-22.43	18.5	-5.01
Return On Equity %	-72.04	-37.38	-48.8	54.97	-8.89
Return on Common Equity	-65.2	-33.86	-40.29	55.36	-8.94
Margin Analysis
Gross Profit Margin %	-	86.61	87.69	96.96	85.82
SG&A Margin	-	187.33	89.73	24.09	56.75
EBITDA Margin %	-	-583.41	-172.61	41.81	-26.25
EBITA Margin %	-	-604.56	-183.56	39.04	-34.37
EBIT Margin %	-	-604.56	-183.56	39.04	-34.37
Income From Continuing Operations Margin %	-	-557.62	-169.79	42.91	-23.59
Net Income Margin %	-	-476.42	-139.48	44.81	-24.22
Net Avail. For Common Margin %	-	-476.42	-139.48	44.81	-24.22
Normalized Net Income Margin	-	-267.32	-75.82	28.72	-15.37
Levered Free Cash Flow Margin	-	-527.04	-189.77	-50.24	-52.43
Unlevered Free Cash Flow Margin	-	-524.17	-186.54	-49.04	-50.42
Asset Turnover
Asset Turnover	-	0.05	0.16	0.62	0.19
Fixed Assets Turnover	-	0.2	0.46	1.7	0.63
Receivables Turnover (Average Receivables)	-	-	4.49	15.98	5.18
Inventory Turnover (Average Inventory)	0.05	0.23	0.38	0.37	0.55
Short Term Liquidity
Current Ratio	17.66	4.81	2.25	4.71	5.15
Quick Ratio	17.04	4.46	1.97	2.29	4.71
Operating Cash Flow to Current Liabilities	-3.63	-1.53	-0.91	2.05	-0.31
Days Sales Outstanding (Average Receivables)	-	-	81.24	22.85	70.69
Days Outstanding Inventory (Average Inventory)	7.38T	1.56T	953	973.72	667.26
Average Days Payable Outstanding	597.75	351.47	378.68	645.9	231.76
Cash Conversion Cycle (Average Days)	-	-	655.56	350.66	506.19
Long Term Solvency
Total Debt/Equity	5.77	26.2	73.75	66.19	58.52
Total Debt / Total Capital	5.45	20.76	42.45	39.83	36.92
LT Debt/Equity	5.28	24.57	56.01	57.23	50.45
Long-Term Debt / Total Capital	5	19.47	32.24	34.43	31.82
Total Liabilities / Total Assets	10.52	31.74	53.64	50.78	47.05
EBIT / Interest Expense	-128.16	-131.77	-35.52	20.31	-10.69
EBITDA / Interest Expense	-125.45	-126.26	-33.13	21.93	-7.89
(EBITDA - Capex) / Interest Expense	-181.07	-195.05	-51.04	13.66	-16.47
Total Debt / EBITDA	-0.2	-0.66	-1.31	1.57	-7.34
Net Debt / EBITDA	2.59	1.37	0.29	0.31	6.31
Total Debt / (EBITDA - Capex)	-0.14	-0.43	-0.85	2.52	-3.52
Net Debt / (EBITDA - Capex)	1.8	0.88	0.19	0.5	3.02
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	271.26	440.35	-53.08
Gross Profit, 1 Yr. Growth %	-102.68	-10.37T	275.9	497.48	-58.47
EBITDA, 1 Yr. Growth %	260.62	30.59	9.84	-230.88	-129.47
EBITA, 1 Yr. Growth %	249.44	33.26	12.72	-214.93	-141.31
EBIT, 1 Yr. Growth %	249.44	33.26	12.72	-214.93	-141.31
Earnings From Cont. Operations, 1 Yr. Growth %	281.17	-4.73	13.04	-236.57	-125.8
Net Income, 1 Yr. Growth %	250.95	-8.68	8.69	-273.6	-125.37
Normalized Net Income, 1 Yr. Growth %	193.38	42.24	5.3	-304.7	-125.16
Diluted EPS Before Extra, 1 Yr. Growth %	-39.78	-20.05	7.5	-270.42	-124.98
Accounts Receivable, 1 Yr. Growth %	-	-	166.13	9.05	77.6
Inventory, 1 Yr. Growth %	294.48	221.09	73.86	14.64	80.3
Net Property, Plant and Equip., 1 Yr. Growth %	184.96	98.2	43.73	46.21	12.28
Total Assets, 1 Yr. Growth %	130.5	24.63	14.36	67.05	38.93
Tangible Book Value, 1 Yr. Growth %	-46.57T	-0.76	-16.86	78.37	45.16
Common Equity, 1 Yr. Growth %	-50.24T	-0.67	-16.7	78.04	45.21
Cash From Operations, 1 Yr. Growth %	181.32	62.07	23.89	-298.95	-121.38
Capital Expenditures, 1 Yr. Growth %	226.01	60.29	8.92	-7.25	-18.57
Levered Free Cash Flow, 1 Yr. Growth %	152.03	51.24	33.68	43.04	-593.2
Unlevered Free Cash Flow, 1 Yr. Growth %	153.34	51.38	32.12	42.04	-482.26
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	78.42	-	347.89	59.24
Gross Profit, 2 Yr. CAGR %	-17.94	66.04	1.86T	373.91	57.52
EBITDA, 2 Yr. CAGR %	144.96	117.01	19.77	19.9	-37.9
EBITA, 2 Yr. CAGR %	139.52	115.79	22.56	13.82	-31.1
EBIT, 2 Yr. CAGR %	139.52	115.79	22.56	13.82	-31.1
Earnings From Cont. Operations, 2 Yr. CAGR %	192.5	90.56	3.78	24.25	-40.64
Net Income, 2 Yr. CAGR %	187.6	79.03	-0.37	37.36	-33.64
Normalized Net Income, 2 Yr. CAGR %	122.26	104.28	22.38	46.81	-28.31
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-30.61	-7.29	35.53	-34.75
Accounts Receivable, 2 Yr. CAGR %	-	-	-	70.35	39.16
Inventory, 2 Yr. CAGR %	89.96	255.9	136.27	41.17	43.77
Net Property, Plant and Equip., 2 Yr. CAGR %	100.21	137.65	68.78	44.97	28.12
Total Assets, 2 Yr. CAGR %	143.25	69.49	19.38	38.22	52.34
Tangible Book Value, 2 Yr. CAGR %	168.71	2.05T	-9.17	21.77	60.91
Common Equity, 2 Yr. CAGR %	168.7	2.13T	-9.04	21.78	60.79
Cash From Operations, 2 Yr. CAGR %	123.73	113.53	41.7	56.99	-34.78
Capital Expenditures, 2 Yr. CAGR %	147.21	128.6	32.13	0.51	-13.1
Levered Free Cash Flow, 2 Yr. CAGR %	-	95.24	42.19	38.28	-16.3
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	95.83	41.43	36.99	-17.21
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	330.6	127.78	-	111.15
Gross Profit, 3 Yr. CAGR %	-	310.45	118.02	1.22T	110.5
EBITDA, 3 Yr. CAGR %	-	98.62	72.94	23.36	-24.9
EBITA, 3 Yr. CAGR %	-	97	73.79	19.96	-18.81
EBIT, 3 Yr. CAGR %	-	97	73.79	19.96	-18.81
Earnings From Cont. Operations, 3 Yr. CAGR %	-	101.25	60.12	13.72	-26.42
Net Income, 3 Yr. CAGR %	-	96.21	51.59	19.89	-21.78
Normalized Net Income, 3 Yr. CAGR %	-	91.54	63.79	45.27	-18.51
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-19.71	13.67	-22.87
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-	72.73
Inventory, 3 Yr. CAGR %	-	126.29	180.29	85.66	53.17
Net Property, Plant and Equip., 3 Yr. CAGR %	-	99.54	100.98	60.9	33.13
Total Assets, 3 Yr. CAGR %	-	94.64	48.66	33.53	38.45
Tangible Book Value, 3 Yr. CAGR %	-	92.79	626.44	13.74	29.12
Common Equity, 3 Yr. CAGR %	-	92.84	645.82	13.78	29.14
Cash From Operations, 3 Yr. CAGR %	-	100.93	78.09	58.67	-19.23
Capital Expenditures, 3 Yr. CAGR %	-	113.97	78.55	17.43	-6.3
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	72.08	42.47	-2.16
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	71.76	41.63	-3.26
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	337.43	97.39
Gross Profit, 5 Yr. CAGR %	-	-	-	334.74	91.44
EBITDA, 5 Yr. CAGR %	-	-	-	62.31	14.81
EBITA, 5 Yr. CAGR %	-	-	-	58.18	20.04
EBIT, 5 Yr. CAGR %	-	-	-	58.18	20.04
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	65.94	7.66
Net Income, 5 Yr. CAGR %	-	-	-	70.13	8.94
Normalized Net Income, 5 Yr. CAGR %	-	-	-	72.21	17.7
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-26.06
Inventory, 5 Yr. CAGR %	-	-	-	87.37	114.6
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	75.6	67.86
Total Assets, 5 Yr. CAGR %	-	-	-	69.73	50.12
Tangible Book Value, 5 Yr. CAGR %	-	-	-	60.42	297.51
Common Equity, 5 Yr. CAGR %	-	-	-	60.45	303.72
Cash From Operations, 5 Yr. CAGR %	-	-	-	82.05	19.16
Capital Expenditures, 5 Yr. CAGR %	-	-	-	58.16	33.86
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	28.98
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	28.27